BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 6983324)

  • 1. Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy.
    Hoikka V; Savolainen K; Karjalainen P; Alhava EM; Sivenius J
    Ann Clin Res; 1982 Apr; 14(2):72-5. PubMed ID: 6983324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant osteomalacia in epileptic outpatients.
    Hoikka V; Savolainen K; Alhava EM; Sivenius J; Karjalainen P; Parvianinen M
    Ann Clin Res; 1982 Jun; 14(3):129-32. PubMed ID: 7137882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia.
    Collins N; Maher J; Cole M; Baker M; Callaghan N
    Q J Med; 1991 Feb; 78(286):113-22. PubMed ID: 1851568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anticonvulsant osteomalacia with vitamin D.
    Christiansen C; Rodbro P
    Calcif Tissue Res; 1976 Aug; 21 Suppl():252-9. PubMed ID: 782665
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of long term anticonvulsant therapy on serum calcium, phosphate and alkaline phosphatase in Nigerian epileptic patients.
    Apantaku JB; Afonja OA; Boyo AE
    Trop Geogr Med; 1975 Dec; 27(4):418-21. PubMed ID: 1216324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteomalacia with long-term anticonvulsant therapy in epilepsy.
    Dent CE; Richens A; Rowe DJ; Stamp TC
    Br Med J; 1970 Oct; 4(5727):69-72. PubMed ID: 5312062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term vitamin D2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia.
    Mosekilde L; Melsen F; Christensen MS; Lund B; Sorenson OH
    Acta Med Scand; 1977; 201(4):303-7. PubMed ID: 300547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a prospective study.
    Krishnamoorthy G; Nair R; Sundar U; Kini P; Shrivastava M
    Neurol India; 2010; 58(2):213-9. PubMed ID: 20508338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced 2,25-dihydroxyvitamin D and 24,25-dihydroxyvitamin D in epileptic patients receiving chronic combined anticonvulsant therapy.
    Christensen CK; Lund B; Lund BJ; Sørensen OH; Nielsen HE; Mosekilde L
    Metab Bone Dis Relat Res; 1981; 3(1):17-22. PubMed ID: 6973685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of anticonvulsant drug-induced bone disease.
    Drezner MK
    Epilepsy Behav; 2004 Feb; 5 Suppl 2():S41-7. PubMed ID: 15123011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteopathies, calcium- and vitamin D metabolism errors during anti-epileptic long term therapy].
    Kruse R
    Bibl Psychiatr; 1975; (151):114-43. PubMed ID: 168863
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology behind anticonvulsant osteomalacia.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Neurol Scand Suppl; 1983; 94():21-8. PubMed ID: 6576595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy.
    Pylypchuk G; Oreopoulos DG; Wilson DR; Harrison JE; McNeill KG; Meema HE; Ogilvie R; Sturtridge WC; Murray TM
    Can Med Assoc J; 1978 Mar; 118(6):635-8. PubMed ID: 418865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D.
    Davie MW; Emberson CE; Lawson DE; Roberts GE; Barnes JL; Barnes ND; Heeley AF
    Q J Med; 1983; 52(205):79-91. PubMed ID: 6603629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia.
    Christiansen C; Rodbro P; Munck O
    Br Med J; 1975 May; 2(5967):363-5. PubMed ID: 165857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial and maintenance dose of vitamin D2 in the treatment of anticonvulsant osteomalacia.
    Christiansen C; Rodbro P
    Acta Neurol Scand; 1974; 50(5):631-41. PubMed ID: 4547902
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment with high-dose oral vitamin D2 in patients with jejunoileal bypass for morbid obesity. Effects on calcium and magnesium metabolism, vitamin D metabolites, and faecal lag time.
    Charles P; Mosekilde L; Søndergård K; Jensen FT
    Scand J Gastroenterol; 1984 Nov; 19(8):1031-8. PubMed ID: 6335925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy.
    Hoikka V; Savolainen K; Alhava EM; Sivenius J; Karjalainen P; Repo A
    Acta Neurol Scand; 1981 Aug; 64(2):122-31. PubMed ID: 7324878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant drug therapy in human pregnancy: effects on serum concentrations of vitamin D metabolites in maternal and cord blood.
    Markestad T; Ulstein M; Strandjord RE; Aksnes L; Aarskog D
    Am J Obstet Gynecol; 1984 Oct; 150(3):254-8. PubMed ID: 6091458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term effects of anti-epileptic treatment on the blood calcium, phosphates and alkaline phosphatase].
    Gasparoni MC; Martini C; Garibaldi E; Colombo A
    Minerva Pediatr; 1977 Jun; 29(21):1373-7. PubMed ID: 882080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.